Empagliflozin Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

• News
• Research
• Blogs
• Podcasts
• Alerts
• Clinical Trials

The Treatment Effects of Empagliflozin on Renal Outcomes in Cardiorenal Syndrome Type 1
Condition:   Empagliflozin in Cardiorenal Syndrome Type 1 Interventions:   Drug: Empagliflozin 10 MG;   Drug: Placebo Sponsor:   Chulalongkorn University Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 11, 2023 Category: Research Source Type: clinical trials

A Study to Determine the Efficacy and Safety of Finerenone and SGLT2i in Combination in Hospitalized Patients With Heart Failure (CONFIRMATION-HF)
Condition:   Heart Failure Interventions:   Drug: Finerenone;   Drug: Empagliflozin Sponsors:   Colorado Prevention Center;   Saint Luke's Hospital of Kansas City;   Bayer Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 6, 2023 Category: Research Source Type: clinical trials